Clinical trials
Gynecological Cancer clinical trials
Below are recruiting gynecological cancer clinical trials, each written for real people, not researchers. We’re tracking 178 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06619769Recruiting
Online program for sexual health after gynecologic cancer
This trial tests an online program called eSense to help with sexual concerns after gynecologic cancer. It might help if you have had gynecologic cancer and are bothered by sexual difficulties.
Vancouver, British ColumbiaAges 19 years+ - NCT05733806Recruiting
Study for rare gynecologic cancers
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
MilanAges Any age - NCT04760327RecruitingPhase 2
Electrotherapy for returning gynecologic cancers
This Phase 2 study tests electrotherapy (a way to help treatment reach tumor cells) for gynecologic cancers that have come back after standard treatments were used up. You may be considered if your overall health allows anesthesia and if certain cancer spread and medical safety issues do not apply.
LjubljanaAges 18–105 - NCT03420118Recruiting
Study of tumor and blood markers in gynecologic cancers
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
Toronto, OntarioAges 18 years+ - NCT07120100Recruiting
TMS for nerve pain from cancer chemo in breast/gyne cancer survivors
This trial tests if transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can reduce nerve pain caused by chemotherapy in women who have had breast or gynecologic cancer. You may be eligible if you have ongoing nerve pain that hasn't been helped by standard pain medications.
Salt Lake City, UtahAges 18 years+ - NCT06904339Recruiting
Sexual health communication during gynecologic cancer care
This trial looks at ways to improve how doctors and patients talk about sexual health concerns during and after gynecologic cancer treatment. You might be able to join if you are currently or have recently been treated for gynecologic cancer and have some sexual health concerns.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07121738Recruiting
Lifestyle program for gynecologic cancer survivors
This study tests a lifestyle medicine program for people who have finished chemotherapy for gynecologic cancer. The program includes healthy living guidance to help you recover and feel better.
Orlando, FloridaAges 18 years+ - NCT05776693Enrolling by invitation
Understanding needs and support in people with gynecologic cancer
This study asks people with gynecologic cancer about their physical and emotional well-being, social support, and what kind of help they need. The goal is to better understand supportive care needs so care can be improved.
TaipeiAges 20–100 - NCT05787561RecruitingPhase 2
Avutometinib plus defactinib for certain gyn cancer
This Phase 2 trial tests two targeted medicines—avutometinib and defactinib—in people with mesonephric (or mesonephric-like) gynecologic cancer that has returned or spread. It aims to shrink tumors and control the disease by targeting specific cancer signals.
Basking Ridge, New JerseyAges 18 years+ - NCT06553612Recruiting
Supportive care planning after gynecological cancer treatment
This study compares a special day-hospital visit focused on supportive care needs to standard follow-up for people who have finished initial treatment for ovarian or endometrial cancer. The goal is to see if the special visit helps more people get the supportive care they need.
BesançonAges 18 years+ - NCT07042243Recruiting
Florida ASCENT cancer study for patients and providers
This study looks at cancer care in Florida. If you have had cancer in the past and are not currently getting active treatment (like chemotherapy or radiation), this study may help researchers understand how to improve care.
Gainesville, FloridaAges 18–100 - NCT07055854RecruitingPhase 1
Mindfulness program for better sex after breast or gynecologic cancer
This study tests an online mindfulness program to help women with breast or gynecologic cancer improve their sexual health. The program is designed for survivors who have concerns about their sex life after treatment.
Corvallis, OregonAges 18 years+ - NCT03740503Recruiting
Study genes in people who respond unusually to treatment
This study looks at stored tumor samples to understand why some people respond much better or much worse than expected. The goal is to learn what the tumor’s genes might be telling doctors about response to treatment.
Toronto, OntarioAges 18 years+ - NCT06580002RecruitingPhase 2
Can Riluzole Help with Chemo Brain? A Pilot Study
This study tests if a medicine called riluzole (currently used for ALS) can help with 'chemo brain' – memory and thinking problems after cancer treatment. It is for people who feel their mental sharpness has declined after breast cancer therapy, certain chemotherapies, or brain radiation.
Orange, CaliforniaAges 18 years+ - NCT04075305Recruiting
Study measuring radiation treatment outcomes with an MR-Linac
This study follows what happens when radiation treatment is guided using an MR-Linac (a special machine that combines MRI imaging with radiation). It may help improve how radiation therapy is planned and assessed, especially for people who can safely have MRI scans.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT04273061RecruitingPhase 2
Atezolizumab for tumors that look sensitive on DNA/RNA testing
This Phase 2 study tests atezolizumab, an immunotherapy drug, in people with advanced, incurable solid tumors whose tumor DNA/RNA suggests they may respond. The goal is to see if the treatment works better for patients selected by these lab results.
Vancouver, British ColumbiaAges 18 years+ - NCT05053230Recruiting
At-home integrative program for people living with cancer
This study tests an at-home integrative medicine program (supportive, whole-person care) to see if it helps symptoms like fatigue for people affected by cancer. You may be assigned to the program or a comparison group, and you’ll complete questionnaires and study check-ins from home.
Basking Ridge, New JerseyAges 18 years+ - NCT05142033Recruiting
Cancer or precancer testing using DNA sequencing results
This trial helps doctors study and analyze cancer- or precancer-related DNA information. If you’re 18 or older and can consent, your results may help researchers understand the biology of your condition and guide future care.
Marshall, MinnesotaAges 18 years+ - NCT05313191Recruiting
Proton therapy for tumors after prior radiation
This study looks at whether a type of proton beam treatment can be given safely and effectively to tumors that have already been treated with radiation before. It may help people whose tumors came back or persisted after earlier radiation, using a specific proton method called pencil beam scanning.
New York, New YorkAges 18 years+ - NCT05406167Recruiting
Tracking quality of life during radiotherapy with a new system
This study collects information about how you feel and how treatment is delivered while you receive radiotherapy using the RefleXion Medical radiotherapy system. It may help doctors improve care and better understand what affects quality of life during treatment.
Duarte, CaliforniaAges Any age - NCT05961111RecruitingEarly Phase 1
Oncolytic virus injection for advanced solid tumors
This early-phase trial tests an injection of a virus designed to attack cancer cells in people with advanced solid tumors. It is meant for situations where standard treatments have not worked (or you can’t/won’t take them) and when doctors can directly deliver the treatment to a tumor spot.
Linyi, ShandongAges 18–75 - NCT06215950RecruitingPhase 1
CAR-T cell therapy for advanced gynecologic cancer with CD70 protein
This trial tests a new treatment called CAR-T cells that target a protein called CD70 found on some gynecologic cancer cells. It is for people whose cancer has advanced or spread and has not responded to or stopped responding to standard treatments.
Wuhu, AnhuiAges 18 years+ - NCT06284343Recruiting
Gynecologic Cancer and Blood Clot Risk Study
This study looks at the risk of blood clots in women with gynecologic cancers who are starting a new line of cancer treatment. It aims to help doctors better predict and prevent blood clots in patients like you.
RomeAges 18 years+ - NCT06392997Recruiting
Saliva test for gynecologic conditions before surgery
This study is testing a simple saliva sample to see if it can help detect gynecologic conditions (like endometriosis, fibroids, or ovarian/uterine/cervical cancer) before or during surgery. If you are having surgery or a biopsy for one of these issues, your saliva may help improve diagnosis.
AngersAges 18 years+
Hear when a new Gynecological Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gynecological cancer?
- Yes. Clin2 currently lists 178 recruiting gynecological cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gynecological cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gynecological cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.